Ollie's Bargain Outlet Tops Q1 Estimates, Lifts Sales Forecast — Positive
OLLI Investopedia — June 03, 2025Discount retailer Ollie's Bargain Outlet Holdings (OLLI) beat estimates for the first quarter on Tuesday and lifted its sales projections for the full year.

Is it Wise to Retain Camden Property Stock in Your Portfolio for Now? — Positive
CPT Zacks Investment Research — June 03, 2025CPT is set to gain from its diverse A/B quality properties, tech upgrades and healthy balance sheet. However, elevated supply and high debt remain headwinds.

VirTra, Inc. (VTSI) Crossed Above the 200-Day Moving Average: What That Means for Investors — Positive
VTSI Zacks Investment Research — June 03, 2025VirTra, Inc. (VTSI) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VTSI crossed above the 200-day moving average, suggesting a long-term bullish trend.

Ollie's Bargain Outlet (OLLI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
OLLI Zacks Investment Research — June 03, 2025While the top- and bottom-line numbers for Ollie's Bargain Outlet (OLLI) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Dollar General (DG) Reports Q1 Earnings: What Key Metrics Have to Say — Neutral
DG Zacks Investment Research — June 03, 2025While the top- and bottom-line numbers for Dollar General (DG) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Signet (SIG) Q1 Earnings: A Look at Key Metrics — Positive
SIG Zacks Investment Research — June 03, 2025The headline numbers for Signet (SIG) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Donaldson (DCI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates — Neutral
DCI Zacks Investment Research — June 03, 2025While the top- and bottom-line numbers for Donaldson (DCI) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Earnings Growth & Price Strength Make Bank of America (BAC) a Stock to Watch — Positive
BAC Zacks Investment Research — June 03, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Earnings Growth & Price Strength Make Lam Research (LRCX) a Stock to Watch — Positive
LRCX Zacks Investment Research — June 03, 2025The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

SIG Sparkles in Earnings, PINS & XYZ Move Higher on Upgrades — Positive
XYZ Schwab Network — June 03, 2025Signet Jewelers (SIG) rallied 10% after posting an earnings beat. Diane King Hall talks about the numbers catching investor interest and discusses ways the company is battling tariff uncertainty.

Why Visa (V) is a Top Stock for the Long-Term — Positive
V Zacks Investment Research — June 03, 2025The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Is Shell (SHEL) a Buy as Wall Street Analysts Look Optimistic? — Positive
SHEL Zacks Investment Research — June 03, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Levi & Korsinsky Launches Fraud Investigation on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders — Neutral
RCKT Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.

Capital Bancorp: Book Value Increased By Double Digit Percentage — Positive
CBNK Seeking Alpha — June 03, 2025Capital Bancorp's recent acquisition has accelerated earnings growth, with Q1 net profit up 79% year-over-year and EPS at $0.84. The bank's strong net interest income and high earnings retention support ongoing balance sheet strength and future growth potential. CRE and construction loans make up 48% of the loan book, but manageable LTV ratios and owner-occupied exposure mitigate risk concerns.

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 2025 — Neutral
INCY Business Wire — June 03, 2025WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #EHA2025--Multiple Incyte Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted at EHA 2025.

July 28, 2025 Deadline Approaching: Join Class Action Against UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky — Neutral
URGN Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151456&wire=1&utm_campaign=30 or contact Joseph E.

Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) Over Potential Securities Fraud Allegations — Neutral
TEM Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.

Did NeuroPace, Inc. (NPCE) Mislead Investors? Levi & Korsinsky Investigates — Neutral
NPCE Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible violations of federal securities laws. NeuroPace issued a press release on May 27, 2025, "announc[ing] the preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for treatment of individuals with drug-resistant idiopathic generalized epilepsy (IGE).

Levi & Korsinsky Notifies DoubleVerify Holdings, Inc. (DV) Investors - Lead Plaintiff Deadline on July 21, 2025 — Neutral
DV Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151458&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.

AI on verge of eight-hour job shift without burnout or break. Is 24-hour AI workday next? — Neutral
WDAY CNBC — June 03, 2025Anthropic CEO Dario Amodei recently predicted generative AI could wipe out up to half of entry-level officer worker jobs. Its Claude 4 generative AI recently reached a breakthrough of working for seven straight computer hours without performance degradation, a notable milestone because chatbots often burn out after an extended stretch of time.
